ARTICLES IN VALUE & OUTCOMES SPOTLIGHT (ISPOR magazine):
Measuring Value—The QALY Turns 50: What Has It Achieved and What Is Its Future? (Nov/Dec 2024)
Including Patients as Partners in Clinical and Outcomes Research (Nov/Dec 2023)
Preparing Young Professionals to Build a Better Future (Sept/Oct 2023)
Understanding Value: US Payers’ Perspectives (May/June 2023)
Can Wearable Devices Help Reduce Health Disparities and Add Value? (Mar/Apr 2023)
Understanding Value: Manufacturers’ Perspectives (July/Aug 2022)
Understanding Value: The Patients’ Perspectives (Mar/Apr 2022)
Understanding Value: The Providers’ Perspective (Nov/Dec 2021)
Understanding Value in Cancer Care (July/Aug 2021)
Expanding the Value Conversation (May/June 2021)
RECENT PEER-REVIEWED PUBLICATIONS:
Yeung K, Cruz M, Tsiao E, Watkins JB, Sullivan SD. Drug use and spending under a formulary informed by cost-effectiveness. JMCP. 2023 Nov;29(11):1175-1183.
Linnerooth S, Penley B, Sauvageau G, et al. Methodology for conducting a comprehensive product review in managed care. JMCP. 2023 ;29(3):237-243.
Drummond MF, Augustovski F, Bhattacharyya D, et al. Challenges of health technology assessment in pluralistic healthcare systems: an ISPOR Council Report. Value Health. 2022;25(8):1257–1267.
Watkins JB, Sullivan SD, Sampsel E, et al. Evolution of the AMCP Format for Formulary Submissions. JMCP. 2020;26(6):696-700.
Watkins JB. ICER's Version of HTA Is Positioned to Guide U.S. Health Care Reform. JMCP. 2020;26(9):1171.
Watkins JB, Tsiao EG. Augmenting Cost-Effectiveness Analysis Will Not Improve Affordability. JMCP. 2020;26(4):407-408.
Watkins JB. Affordability of Health Care: A Global Crisis. Value Health. 2018 Mar;21(3):280-282.
Yeung K, Basu A, Marcum ZA, Watkins JB, Sullivan SD. Impact of a value-based formulary in three chronic disease cohorts. Am J Manag Care. 2017 Mar;23(3 Suppl):S46-S53.
Trosman JR, Weldon CB, Douglas MP, Deverka PA, Watkins JB, Phillips KA. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies. Value Health. 2017 Jan;20(1):40-46.
Yeung K, Basu A, Hansen RN, Watkins JB, Sullivan SD. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures. Med Care. 2017 Feb;55(2):191-198.
